These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24120789)

  • 1. Re: Differences in 24-hour urine composition between apatite and brushite stone formers.
    Assimos DG
    J Urol; 2013 Nov; 190(5):1785-6. PubMed ID: 24120789
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review.
    Hesse A; Heimbach D
    World J Urol; 1999 Oct; 17(5):308-15. PubMed ID: 10552150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a 'common sense diet' on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis.
    Hess B; Mauron H; Ackermann D; Jaeger P
    Eur Urol; 1999 Aug; 36(2):136-43. PubMed ID: 10420035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralogical studies of urine: the relationship of apatite, brushite and struvite to urinary pH.
    ELLIOT JS; QUAIDE WL; SHARP RF; LEWIS L
    J Urol; 1958 Oct; 80(4):269-71. PubMed ID: 13576608
    [No Abstract]   [Full Text] [Related]  

  • 6. Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism?
    Bouzidi H; de Brauwere D; Daudon M
    Nephrol Dial Transplant; 2011 Feb; 26(2):565-72. PubMed ID: 20659907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate treatment of recurrent calcium stone disease.
    Heyburn PJ; Robertson WG; Peacock M
    Nephron; 1982; 32(4):314-9. PubMed ID: 7167209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple technique for the determination of urinary state of saturation with respect to brushite.
    Pak CY; Chu S
    Invest Urol; 1973 Nov; 11(3):211-5. PubMed ID: 4749421
    [No Abstract]   [Full Text] [Related]  

  • 10. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occasional urinary tract infections and urinary depletion effect mask RTA and carbonate-apatite formation in a strong urinary stone former.
    Laube N; Thomas E; Kovács A; Meissner A
    Eur J Med Res; 2006 Jul; 11(7):290-4. PubMed ID: 16899423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of varying water intake and of other measures on the relative saturation of stone forming salts in the urine of spinal cord patients.
    Nuseibeh I; Burr RG
    Paraplegia; 1979 Sep; 17(3):363-70. PubMed ID: 503570
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study.
    Pourmand G; Nasseh H; Sarrafnejad A; Mojtahedi A; Mehrsai A; Alamdari DH; Nourijelyani K
    Urol Int; 2006; 76(2):163-8. PubMed ID: 16493220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers.
    Rivera M; Jaeger C; Yelfimov D; Krambeck AE
    Urology; 2017 Jan; 99():23-26. PubMed ID: 27634734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of uricine.
    Pinto B; Rocha E
    Invest Urol; 1977 Sep; 15(2):155-7. PubMed ID: 20424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified estimate of the ion-activity product of calcium phosphate in urine.
    Tiselius HG
    Eur Urol; 1984; 10(3):191-5. PubMed ID: 6547093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal-associated nephropathy in patients with brushite nephrolithiasis.
    Evan AP; Lingeman JE; Coe FL; Shao Y; Parks JH; Bledsoe SB; Phillips CL; Bonsib S; Worcester EM; Sommer AJ; Kim SC; Tinmouth WW; Grynpas M
    Kidney Int; 2005 Feb; 67(2):576-91. PubMed ID: 15673305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
    Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
    J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism?
    Assimos D
    J Urol; 2011 Apr; 185(4):1313-4. PubMed ID: 22098968
    [No Abstract]   [Full Text] [Related]  

  • 20. Using 24-hour urinalysis to predict stone type.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    J Urol; 2013 Dec; 190(6):2106-11. PubMed ID: 23764079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.